<DOC>
	<DOCNO>NCT01059240</DOCNO>
	<brief_summary>Background : - Spinal muscular atrophy ( SMA ) degenerative incurable neuromuscular disorder cause mutation survival motor neuron gene , SMN1 , find chromosome 5 . It lead inherit cause infant mortality . SMA carrier ( genetic mutation disease ) often unaware status test . - Researchers study prevalence SMA carriers general population , information collect come population within United States , Europe , Asia . Very study perform Africa . Furthermore , information provide much information regard carrier frequency base ethnic background ancestry . To address problem , researcher interest study prevalence SMA genetic mutation sub-Saharan nation Mali . Objectives : - To collect blood sample use study genetic data relate spinal muscular atrophy . Eligibility : - Healthy volunteer least 18 year age . - Volunteers Malian ancestry nationality . Study Location : - &lt; TAB &gt; Bamako , Mali , West Africa Design : - The study first collect blood sample small group volunteer run initial SMA carrier test resolve technical difficulty continue study . - Participants complete questionnaire personal family medical history , include question illness , stillborns , miscarriage , provide blood sample genetic research testing .</brief_summary>
	<brief_title>SMN Copy Number Distribution Mali , West Africa</brief_title>
	<detailed_description>Objective Spinal muscular atrophy ( SMA ) autosomal recessive motor neuron disease cause mutation survival motor neuron gene , SMN1 . The objective study determine SMN copy number distribution Malian population compare publish data obtain elsewhere . It anticipate study help refine knowledge SMA assess distribution SMN copy number , SMA carrier frequency sub-Saharan nation , thus expand information base available clinician patient consider SMA carrier test . Study Population The study population include 1400 adult ( 18 year age old ) volunteer . Design Blood sample volunteer collect student School Medicine , Pharmacy , Dentistry ( FMPOS ) University Bamako , consist ethnically diverse population representative Malian ethnicity . No therapy provide study participant . Outcome Measures Outcome measure phase 1 DNA extraction yield sufficient quantity quality SMN genotyping LabCorp least 90 % sample . Outcome measure phase 2 frequency SMA carrier ( SMN1 deletion heterozygote ) SMN1 SMN2 copy number distribution Mali . Abbreviations Definition Terms - SMA : Spinal Muscular Atrophy - SMN : Survival Motor Neuron - SMN1 : Survival Motor Neuron Telomeric - SMN2 : Survival Motor Neuron Centromeric</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Muscular Atrophy , Spinal</mesh_term>
	<mesh_term>Muscular Atrophy</mesh_term>
	<criteria>INCLUSION CRITERIA : Medical student FMPOS Malian ancestry nationality 18 year age consider study . EXCLUSION CRITERIA : Subjects may eligible participate condition would make single 6 ml blood draw unsafe . Student assistant ineligible study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 31, 2016</verification_date>
	<keyword>Survival Motor Neuron 1 ( SMN1 )</keyword>
	<keyword>Survival Motor Neuron 2 ( SMN2 )</keyword>
	<keyword>Spinal Muscular Atrophy ( SMA )</keyword>
	<keyword>SMN Copy Number Mali</keyword>
	<keyword>Spinal Muscular Antrophy</keyword>
	<keyword>SMA</keyword>
</DOC>